We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

[RIO DE JANEIRO] A Brazilian consortium has unveiled a multi-billion-dollar strategy aimed at making the country a world leader in biotechnology.

The Brazilian Forum of Biotechnology Competitiveness, which includes government agencies, the private sector and academic institutions, announced the plan last week (4 July).

It identifies research areas of that have the potential to boost the competitiveness of Brazilian industry, increase Brazil's participation in global trade, speed up its economic growth, and create jobs.

The overall cost of putting the plan into action will be US$3 billion, which will come from the public and private sectors.

Of this, more than US$530 million is earmarked for health-related biotechnology, including the production of drugs and vaccines for neglected diseases and cutting-edge research in the fields of genomics, proteomics, nano-biotechnology and stem-cell science.

The plan entails creating new funding mechanisms, training, and improving the infrastructure of research institutions.

"It is from an immediate, intense and integrated effort of government, industry and academia that Brazil will be capable of appearing, in 10-15 years, among the leaders in the biotechnology industry, especially in the areas of human health, farming and cattle raising and industrial biotechnology," says the document.

The plan will be presented to president Luiz Inácio Lula da Silva for approval later this year.

Link to full text of the National Strategy for Biotechnology [342KB]

Related topics